Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37342943)

  • 1. A DNA damage response-like phenotype defines a third of colon cancers at onset.
    Mauro S; Bolognesi MM; Villa N; Capitoli G; Furia L; Mascadri F; Zucchini N; Totis M; Faretta M; Galimberti S; Bovo G; Cattoretti G
    FASEB J; 2023 Jul; 37(7):e23020. PubMed ID: 37342943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copy Number Amplification of DNA Damage Repair Pathways Potentiates Therapeutic Resistance in Cancer.
    Wu Z; Li S; Tang X; Wang Y; Guo W; Cao G; Chen K; Zhang M; Guan M; Yang D
    Theranostics; 2020; 10(9):3939-3951. PubMed ID: 32226530
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic opportunities within the DNA damage response.
    Pearl LH; Schierz AC; Ward SE; Al-Lazikani B; Pearl FM
    Nat Rev Cancer; 2015 Mar; 15(3):166-80. PubMed ID: 25709118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
    Parikh AR; He Y; Hong TS; Corcoran RB; Clark JW; Ryan DP; Zou L; Ting DT; Catenacci DV; Chao J; Fakih M; Klempner SJ; Ross JS; Frampton GM; Miller VA; Ali SM; Schrock AB
    Oncologist; 2019 Oct; 24(10):1340-1347. PubMed ID: 31040255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.
    Evans JR; Zhao SG; Chang SL; Tomlins SA; Erho N; Sboner A; Schiewer MJ; Spratt DE; Kothari V; Klein EA; Den RB; Dicker AP; Karnes RJ; Yu X; Nguyen PL; Rubin MA; de Bono J; Knudsen KE; Davicioni E; Feng FY
    JAMA Oncol; 2016 Apr; 2(4):471-80. PubMed ID: 26746117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
    Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
    Front Immunol; 2021; 12():665002. PubMed ID: 34367132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An insight into understanding the coupling between homologous recombination mediated DNA repair and chromatin remodeling mechanisms in plant genome: an update.
    Banerjee S; Roy S
    Cell Cycle; 2021 Sep; 20(18):1760-1784. PubMed ID: 34437813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DNA damage response network in the treatment of head and neck squamous cell carcinoma.
    Psyrri A; Gkotzamanidou M; Papaxoinis G; Krikoni L; Economopoulou P; Kotsantis I; Anastasiou M; Souliotis VL
    ESMO Open; 2021 Apr; 6(2):100075. PubMed ID: 33714009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma.
    Teo MY; Bambury RM; Zabor EC; Jordan E; Al-Ahmadie H; Boyd ME; Bouvier N; Mullane SA; Cha EK; Roper N; Ostrovnaya I; Hyman DM; Bochner BH; Arcila ME; Solit DB; Berger MF; Bajorin DF; Bellmunt J; Iyer G; Rosenberg JE
    Clin Cancer Res; 2017 Jul; 23(14):3610-3618. PubMed ID: 28137924
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting DNA damage repair pathways in pancreas cancer.
    Crowley F; Park W; O'Reilly EM
    Cancer Metastasis Rev; 2021 Sep; 40(3):891-908. PubMed ID: 34403012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer.
    van der Doelen MJ; Isaacsson Velho P; Slootbeek PHJ; Pamidimarri Naga S; Bormann M; van Helvert S; Kroeze LI; van Oort IM; Gerritsen WR; Antonarakis ES; Mehra N
    Eur J Cancer; 2020 Sep; 136():16-24. PubMed ID: 32634759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
    Ronchetti L; Melucci E; De Nicola F; Goeman F; Casini B; Sperati F; Pallocca M; Terrenato I; Pizzuti L; Vici P; Sergi D; Di Lauro L; Amoreo CA; Gallo E; Diodoro MG; Pescarmona E; Vitale I; Barba M; Buglioni S; Mottolese M; Fanciulli M; De Maria R; Maugeri-Saccà M
    Int J Cancer; 2017 Jun; 140(11):2587-2595. PubMed ID: 28233295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting DNA repair defects in breast cancer: from chemotherapy to immunotherapy.
    Aktas BY; Guner G; Guven DC; Arslan C; Dizdar O
    Expert Rev Anticancer Ther; 2019 Jul; 19(7):589-601. PubMed ID: 31181965
    [No Abstract]   [Full Text] [Related]  

  • 14. A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancer.
    Ding K; He Y; Wei J; Fu S; Wang J; Chen Z; Zhang H; Qu Y; Liang K; Gong X; Qiu L; Chen D; Xiao B; Du H
    Front Immunol; 2022; 13():943090. PubMed ID: 36081518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of mutations in DNA damage repair pathway gene in Chinese patients with hepatocellular carcinoma.
    Li J; Li N; Azhar MS; Liu L; Wang L; Zhang Q; Sheng L; Wang J; Feng S; Qiu Q; Xiao Y
    Sci Rep; 2022 Jul; 12(1):12330. PubMed ID: 35853969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse immune response of DNA damage repair-deficient tumors.
    Qing T; Jun T; Lindblad KE; Lujambio A; Marczyk M; Pusztai L; Huang KL
    Cell Rep Med; 2021 May; 2(5):100276. PubMed ID: 34095878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage response--a double-edged sword in cancer prevention and cancer therapy.
    Tian H; Gao Z; Li H; Zhang B; Wang G; Zhang Q; Pei D; Zheng J
    Cancer Lett; 2015 Mar; 358(1):8-16. PubMed ID: 25528631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yeast-based screening of cancer mutations in the DNA damage response protein Mre11 demonstrates importance of conserved capping domain residues.
    Harris C; Savas J; Ray S; Shanle EK
    Mol Biol Rep; 2021 May; 48(5):4107-4119. PubMed ID: 34075539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of the relationship of DNA mismatch repair with clinicopathologic features and prognosis of colon cancer].
    Qin Q; Ying J; Lyu N; Guo L; Zhi W; Zhou A; Wang J
    Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):591-6. PubMed ID: 26714599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage response and prostate cancer: defects, regulation and therapeutic implications.
    Karanika S; Karantanos T; Li L; Corn PG; Thompson TC
    Oncogene; 2015 May; 34(22):2815-22. PubMed ID: 25132269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.